A major breakthrough in the treatment of epilepsy: latest price and cost analysis of the new generation of anti-epileptic drugs Vigabatrin/vigabatrin

Vigabatrin/vigabatrin is a drug used to treat infantile spasms and refractory epilepsy. Its price and purchase channels are the focus of many patients and their families. At present, Vigabatrin has been officially launched in China and has been included in the medical insurance directory, which provides convenience to domestic patients.

The specifications of Vigabatrin sold in China are usually 500mg*30 bags, and the price is about more than 1,000 yuan. The specific cost may vary depending on the region and hospital policies. After reimbursement through medical insurance, the patient's out-of-pocket portion will be further reduced. It is recommended that patients consult the local hospital pharmacy or medical insurance department for detailed reimbursement policies and price information.

For patients who want to reduce their drug cost burden, purchasing drugs overseas is an option worth considering. The price of the original drug in Hong Kong is relatively close to the people. The price of 500mg*100 bags of Vigabatrin is about more than one thousand yuan, and the price/performance ratio is significantly higher than that in China. In addition, the price of the Lao version of generic drugs is more affordable. The price of drugs with the same specifications is only a few hundred yuan. The ingredients of the drugs are basically the same as the original drugs, and the quality and efficacy are also guaranteed. However, when choosing to purchase drugs overseas, you need to pay attention to the legality and safety of the drugs, ensure that they are purchased through formal channels, and avoid the risk of fake or inferior drugs.

Whether choosing domestic medical insurance reimbursement or overseas drug purchase, patients should make decisions under the guidance of a doctor. As a powerful anti-epileptic drug, Vigabatrin needs to be used strictly in compliance with medical advice and regular monitoring of side effects such as vision to ensure the safety and effectiveness of treatment. For patients with limited financial conditions, they can comprehensively consider domestic medical insurance policies and the cost-effectiveness of overseas drug purchases to choose the most suitable drug purchase method for them.

Reference materials:https://www.sabril.net/